Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization.
Osman ÖcalJuozas KupčinskasEgidijus MorkunasHolger AmthauerKerstin SchüttePeter MalfertheinerHeinz Josef KlümpenChristian SengelJulia BenckertRicarda SeidenstickerBruno SangroMoritz WildgruberMaciej PechPeter BartensteinJens RickeMax SeidenstickerPublished in: EJNMMI research (2021)
In advanced HCC patients receiving 90Y radioembolization combined with sorafenib, baseline IL6 values proved to be prognostic, confirming previous findings in patients undergoing 90Yradioembolization. IL6 might be useful for patient selection or stratification in future trials.